Brain oxygen booster falls short in early trial
NCT ID NCT00174980
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a drug called Oxycyte in people with severe head injuries to see if it could safely increase oxygen levels in the brain. Only 9 patients took part before the study was stopped early. The main goal was to measure how the drug affected brain chemistry, but no clear results are available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRAUMATIC BRAIN INJURY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Virginia Commonwealth University Medical Center
Richmond, Virginia, 23298, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Spinal zaps could reboot breathing after brain injury
- Could music be medicine for the injured brain?
- Can blood markers predict brain injury outcomes?
- Can a treadmill that adapts to your pace fix uneven steps?
- Can brain training help TBI patients remember to remember?
- Can a natural protein fragment help the brain heal after severe injury?